🇺🇸

Index Intelligence

· daily

Nasdaq 100 Stocks SEC Filings — April 24, 2026

Across 33 filings from NASDAQ-100 related entities, proxy statements dominate (18/33) signaling peak annual meeting season in May-June 2026, with positive executive comp and achievements in biotech/tech (e.g., Immunome exceeded targets 145-150%, Alphabet Gemini launch). Q1 2026 financials show semis rebounding (Intel rev +7.2% YoY to $13.6B, TI +18.6% to $4.8B) amid CHIPS incentives, but mixed elsewhere: telecom softness (Charter rev -1% YoY), coal disruptions (Alpha Met Q1 loss $11M), and sharp declines (ILAG rev -40.1% YoY). Capital returns strong (Comcast $11.7B buybacks/divs reducing shares 5%, TI $1.29B divs), with biotech funding wins (Altimmune $211M for Phase 3 MASH trial). Portfolio trends: Revenue growth avg +10% YoY in reporting cos (5/7), but losses prevalent (Intel $3.7B net loss, Blue Moon $38.8M); positive sentiment 12/33, mixed 10/33. Key implications: Watch proxy votes for equity plan approvals adding shares (Alphabet 200M Class C), semis for foundry ramps, biotechs for catalysts.

16 high priority 17 medium 33 total filings
· daily

S&P 500 Financials Sector SEC Filings — April 24, 2026

The 50 filings in the USA S&P 500 Financials intelligence stream reveal a mix of proxy statements (20+ filings, neutral sentiment) for June 2026 AGMs focusing on director elections, auditor ratifications, and exec comp approvals, alongside 20+ 13F-HR snapshots from asset managers showing heavy tech overweight (Apple, NVDA, AMZN top across portfolios) but notable financials exposure (Visa $134M top at Ninety One, JPM $32M at Alley, BDCs like Ares $40M at Muzinich). Period-over-period trends highlight strong revenue growth in financials/fintech (UP Fintech +56.3% YoY to $612M, First American +16.2% YoY to $1.84B) averaging +30% YoY across growth reporters, but mixed profitability (Flagstar Q1 NI turnaround from -$100M YoY loss to +$21M, yet NII -5% QoQ). Margin compression evident in non-financials (Gravity gross margin -370bps to 35%, Medicure gross profit -10% despite +32% rev), with capital allocation favoring returns (First Am $33.5M buybacks + $56M dividends Q1, News Corp $1B ongoing buyback). No widespread insider trading patterns, but regulatory risks loom (UP Fintech delisting threat). Implications: Bullish on recovering banks/insurers, watch proxy votes and fintech regs for near-term catalysts.

14 high priority 36 medium 50 total filings
· daily

S&P 500 Consumer Staples Sector SEC Filings — April 24, 2026

Across 50 SEC filings for the USA S&P 500 Consumer Staples intelligence stream (despite broader coverage including tech/industrials), key themes include mixed Q1/FY26 earnings with revenue growth averaging +8% YoY in reporters like Procter & Gamble (+7% Q3 sales to $21.2B, organic +3%), Philip Morris (+9.1% to $10.1B), Intel (+7.2%), and Sibanye Stillwater (+15.6%), but persistent margin compression (e.g., P&G core gross -100bps, op -80bps) and earnings volatility from one-offs/restructuring. Proxy season dominates with 20+ AGMs clustered in June 2026, featuring director elections, say-on-pay, equity plan expansions, and governance tweaks like bylaws (JPM, Kontoor). 13F-HR filings (12 total) reveal institutional portfolios heavily tilted to tech megacaps (e.g., Chicago Capital $187M Alphabet, Sumitomo $592M Apple), signaling rotation away from staples amid neutral sentiment. Capital allocation emphasizes dividends (PMI +9% to $1.47/share, Sibanye 131cps) and buybacks (Charter EPS +7.9% via repurchases), with forward catalysts like Honeywell Aerospace spin (3Q26) and Elmet IPO ($120M proceeds). Portfolio-level trends show 5/10 earnings reporters with YoY rev growth >7% but 7/10 with op margin declines avg -50bps, highlighting cost/tariff pressures; actionable now: favor staples with volume growth (P&G Beauty +7%) over volume decliners.

21 high priority 29 medium 50 total filings
· daily

S&P 500 Industrials Sector SEC Filings — April 24, 2026

Across 50 SEC filings from April 24, 2026, primarily 13F-HR holdings reports (25+), proxy statements (10+), and quarterly/annual financials (10+), overarching themes include peak proxy season with strong shareholder support in AGMs, institutional portfolios overwhelmingly tilted to tech/AI giants (Alphabet, Nvidia, Apple topping 80% of 13Fs), and mixed financial performance in reporters with average revenue growth +8.4% YoY across 12 firms (e.g., Sibanye +15.6%, Philip Morris +9.1%) but profitability challenges (5/12 saw net income declines, avg -5.2%). Industrials-relevant signals shine: Trane Technologies expands $1.5B credit facility signaling liquidity for growth; AITX secures construction-site AI orders; Defense Tech cash burn persists. M&A in Peoples Bancorp offers accretion potential spilling into sector stability; urban-gro defaults highlight credit risks. Portfolio-level: No insider trading patterns (absent in filings), capital allocation favors dividends (Sibanye 131 cps, PMI +9% div), with upcoming AGMs as catalysts for equity plan approvals and comp votes.

16 high priority 34 medium 50 total filings
· daily

S&P 500 Energy Sector SEC Filings — April 24, 2026

Across 19 filings in the S&P 500 Energy stream, energy services and midstream firms show mixed Q1 2026 results: revenues grew modestly (SLB +3% YoY, Baker Hughes +2.5% YoY, Kinder Morgan +14% YoY) while Halliburton dipped -0.3% YoY, but net income surged dramatically (Baker +131% YoY to $930M, Halliburton +128.6% YoY to $464M, Kinder +36% YoY to $976M) driven by one-time gains and absent impairments. Devon Energy's merger with Coterra advances amid lawsuits, with supplemental DCF fairness opinions valuing Devon at $37.50-$54.97/share (vs $39.45 close) and meetings set for May 4, 2026. Capital allocation remains shareholder-friendly with SLB's $0.295/share dividend (payable July 9), Kinder's $654M dividends paid, and Baker's cash ballooning to $14.8B post-debt issuance. Non-energy filings (13Fs, REITs, tech) reveal neutral institutional positioning in tech/banks/ETFs with no energy tilt, while SLB announces M&A (OneSubsea/Envirex H1 2026, S&P software H2 2026). Portfolio-level trends indicate improving profitability (avg +98% YoY NI across core energy filers) despite sequential declines (SLB rev -11% QoQ), signaling resilience amid Middle East disruptions but vulnerability to one-offs. Key implication: tactical opportunities in merger arb and services recovery, watch May catalysts.

5 high priority 14 medium 19 total filings
· daily

Dow Jones 30 Stocks SEC Filings — April 24, 2026

Across 50 filings from Dow Jones 30-related and adjacent streams, Q1/FY2026 earnings show mixed results with top-line growth in 6/12 key reporters (avg +6% YoY revenue: PG +7%, Intel +7.2%, SLB +3%, Sibanye +15.6%) offset by pervasive margin compression (avg -100bps: PG -150bps gross, Gravity -370bps gross, SLB adj EBITDA -12%) due to costs, tariffs, and reinvestments. Portfolio transformations dominate industrials (Honeywell Aerospace spin 3Q2026, Solstice completed Oct2025), while telecom/cable faces subscriber erosion (Charter internet -120k, total relationships -1.5% YoY). Institutional 13F-HR filings (17/50) reveal heavy tech concentration (AAPL, AMZN, GOOGL, NVDA top across ProCore, Q Fund, IFM, etc.), signaling conviction in mega-caps amid volatility. Proxy season ramps with 10+ AGMs in June 2026 (VAALCO Jun4, Live Nation Jun11, Vertiv Jun17), focusing on comp, auditors, and share increases. Capital allocation leans defensive (PG adj FCF productivity 82%, SLB div $0.295, ChoiceOne cap ratio 12.9%), but dilution risks loom (MicroVision 61M shares resale). Implications: Favor resilient consumer staples and tech holdings; trim margin-challenged cyclicals like chems/energy.

15 high priority 35 medium 50 total filings
· daily

S&P 500 Consumer Discretionary Sector SEC Filings — April 24, 2026

Across 50 filings in the USA S&P 500 Consumer Discretionary intelligence stream (though heavily featuring financials, SPACs, and 13Fs), key themes include YoY earnings recovery in financials (avg net income +50-180% in 7 reporters like LVS +61%, UP Fintech +179%) offset by QoQ softness (e.g., Ponce -16%, Flagstar down), heavy institutional conviction in mega-cap tech (Apple, Nvidia, Amazon topping 25+ 13Fs), and clustered proxy events for AGMs/share votes in May-June. Aggregate trends show revenue surges (LVS +25% YoY, FAF +16%, UP +56%) with mixed NIM (expansions like Ponce +63bps YoY, compressions elsewhere), deposit/loan growth (avg +2-5% QoQ where reported), and active capital returns ($746M LVS buybacks, $33M FAF repurchases, FBIZ div +17%). No dominant insider trading patterns, but high ownership alignment (Lifetime Brands group 44.4%). Critical developments: Nasdaq delist risks (SHF), PRC regs (UP Fintech), M&A advances (Woori, Willow Lane). Implications: Bullish on gaming/fintech growth plays, caution on small-cap compliance/litigation, monitor AGMs for governance shifts amid tech-heavy portfolios signaling defensive positioning.

15 high priority 35 medium 50 total filings
· daily

S&P 500 Healthcare Sector SEC Filings — April 24, 2026

Across 50 filings dated April 24, 2026, primarily from financial institutions and a handful of S&P 500 Healthcare names, Q1 2026 bank earnings dominate with mixed results: 7/10 banks showed YoY net income growth or turnarounds from losses (avg +25% YoY) but QoQ declines in 6/7 (avg -15%), driven by NIM expansions (avg +40bps YoY) offset by higher expenses and softer loan growth (avg -1% QoQ). Healthcare filings reveal positive funding momentum with Citius Pharma raising $5M for LYMPHIR launch, Lucid Diagnostics closing $16.8M offering, and Regeneron highlighting $14.3B 2025 revenues with $3.8B shareholder returns, contrasting neutral biotech proxies (Caribou, Rallybio). 20+ 13F-HR filings indicate portfolio managers overweight ETFs/tech (e.g., Apple, Nvidia top holdings across 15/20), with healthcare exposure in Amicus, Abbott, Masimo via select funds. Capital allocation trends favor buybacks/dividends (e.g., $33.5M repurchases at First American, $75M special dividend at FHLB SF), signaling confidence amid asset quality improvements (NPLs down in 4/7 banks). Key implication: Banking recovery YoY supports healthcare-adjacent stability, but QoQ softness flags deposit/loan pressures; monitor June biotech AGMs for governance catalysts.

16 high priority 34 medium 50 total filings
· daily

S&P 500 Technology Sector SEC Filings — April 23, 2026

Across 26 filings from S&P 500 Technology stream and related sectors, Q1 2026 results reveal mixed performance with strong revenue growth in tech names (avg +17% YoY for ServiceNow +22%, Lam Research +23.8%, IBM +9%, Knowles +16%) offset by expense pressures and flat incomes, while banks show NIM expansions (e.g., Dime 3.21%, Amalgamated +9bps to 3.75%) but rising provisions/NPLs (Amalgamated NPA to 1.08%, Dime NPL $57.1M). Capital allocation favors shareholder returns via buybacks (ServiceNow $2.225B, Lam $3.6B treasury), dividends (Esquire +14% to $0.20, Community West $0.12), and debt management (CHS tender $600M notes). M&A catalysts cluster in Q2 2026 (Pershing Vantage close, multiple bank mergers), with forward guidance stable (Iridium FY service flat-+2%, Knowles Q2 $152-162M rev). Portfolio trends highlight tech outperformance vs financials' credit risks, with 14/20 Q1 reporters mixed sentiment due to YoY income volatility despite top-line gains. Key implication: Rotate into high-growth tech amid bank margin resilience but watch credit deterioration.

10 high priority 16 medium 26 total filings
· daily

Nasdaq 100 Stocks SEC Filings — April 23, 2026

Across 28 filings from NASDAQ-100 and related constituents on April 23, 2026, banking names dominate with mixed Q1 results showing YoY net income growth averaging ~40% (e.g., Richmond Mutual +40%, Dime +67%, Community West +38.6%) driven by NIM expansion (e.g., Amalgamated +9bps to 3.75%, Dime to 3.21%, Community West to 4.30%), but offset by rising provisions/NPLs (Amalgamated NPA to 1.08%, Dime NPL $57.1M). Tech/media leaders like Comcast (revenue +5.3% YoY), Tesla (revenues +16% YoY, gross profit +50%), Lam Research (revenue +23.8% YoY), and Intel (revenue +7% YoY) report solid top-line growth amid content/events, but earnings pressure from costs/restructuring; bullish capital returns surge with Netflix's $25B buyback, T-Mobile's $3.6B program increase to $18.2B, Comcast $1.3B repurchases, and Lam $3.6B treasury buys. Homebuilders like Century Communities face headwinds with revenue -12.6% YoY. Portfolio-level trends highlight NIM resilience vs credit deterioration in banks (6/9 banks with higher provisions/NPLs), robust buybacks/dividends signaling confidence (7 companies announcing/expanding returns), and reiterated guidance (Iridium FY OEBITDA $480-490M, Keurig FY sales $25.9-26.4B). Mergers advance (Richmond/Farmers Q2 close, Community West completed Apr 1), creating M&A catalysts. Overall, mixed sentiment (17/28 mixed) points to resilient growth but credit/opex risks, favoring capital return plays amid stabilizing macros.

11 high priority 17 medium 28 total filings
· daily

S&P 500 Financials Sector SEC Filings — April 23, 2026

Across 50 SEC filings from the USA S&P 500 Financials stream (broadly including banks, insurers, and related services, with some cross-sector overlaps), Q1 2026 results show robust revenue growth averaging 10-15% YoY in 70% of quarterly reporters (e.g., Tesla +16%, Thermo Fisher +6%, PG&E +15%), driven by acquisitions and pricing, but offset by margin compression in 60% (avg -50-150 bps) from higher opex/depreciation and impairments. Capital allocation remains a bright spot with aggressive buybacks (Netflix +$25B, Thermo Fisher $3B, Waste Connections $284M) and dividend hikes (Texas Capital initiates $0.20, CenterPoint guidance intact). Financials-specific trends include NIM expansion/stability (CVB +13 bps YoY to 3.44%, TriCo +5 bps to 4.07%) amid loan growth (Southern Missouri +7.4% YoY), but rising provisions/charge-offs signal credit stress. Forward-looking guidance mostly reaffirmed (Honeywell 3-6% organic growth, PG&E $1.64-1.66 EPS), with M&A/tenders (Capital One Brex, Community Health $600M notes) and equity raises indicating balance sheet maneuvers. Portfolio-level: 8/10 high-materiality filings bullish on returns, mixed earnings highlight resilience but watch credit/opex. Key implication: Favor capital return plays over pure growth amid macro uncertainty.

26 high priority 24 medium 50 total filings
· daily

S&P 500 Consumer Staples Sector SEC Filings — April 23, 2026

Across 50 SEC filings from the USA S&P 500 Consumer Staples intelligence stream (including adjacent sectors), Q1/FY2026 earnings reveal mixed performance with revenue growth averaging +8% YoY in 12 reporting companies (e.g., Mobileye +27%, Keurig Dr Pepper +9.4%, Thermo Fisher +6%), but frequent non-cash impairments (Helen of Troy $886M, Mobileye $3.8B) drove EPS declines in 60% of cases. Capital allocation remains robust, with $30B Walmart buyback authorization, $6B Newmont repurchase, $3B Thermo Fisher repurchases, and dividend hikes (Thermo Fisher +10%, PG&E core EPS guidance $1.64-$1.66 reaffirmed). M&A activity surges (Thermon/CECO merger HSR cleared Apr 2, Helix/Hornbeck announced Apr 22, Masimo/Danaher vote May 1), alongside proxy-heavy calendar for June 2026 annual meetings (20+ filings). Consumer Staples outliers show Walmart's superior cash flow ($41.6B) and profits outpacing sales vs. Helen of Troy's -6.4% sales drop and margin contraction (-400bps Q4 gross). Portfolio trend: Margin expansion in 4/10 earnings (Honeywell +90bps), compression in 5/10 (avg -150bps); strong FCF supports returns amid flat guidance changes. Implications: Favor buyback-heavy names for near-term yield; monitor June catalysts for governance/M&A risks.

18 high priority 32 medium 50 total filings
· daily

S&P 500 Industrials Sector SEC Filings — April 23, 2026

Across 50 SEC filings from S&P 500 Industrials and adjacent sectors on April 23, 2026, Q1 2026 results dominate with mixed sentiment (25/37 scored mixed), revealing YoY revenue growth averaging ~10% in industrials (e.g., Gentherm +11.3%, Mobileye +27%, Honeywell +2% organic) but banking pressures from rising credit provisions (e.g., NBT +$5.6M, Texas Capital $16M) and NIM volatility (expansions like NBT +28bps, compressions like First Citizens -11bps). Margin expansions noted in 8/15 reporting firms (avg +100bps, e.g., Gentherm EBITDA +140bps), offset by impairments (Mobileye $3.8B goodwill) and operational declines (Lockheed cash flow -84% YoY). Capital returns strong with buybacks ($6B Newmont, $250M Mobileye) and dividend hikes (Patterson-UTI +to $0.10, Texas Capital inaugural $0.20), while M&A catalysts abound (Gentherm-Modine HSR cleared, L3Harris $1B DoD investment). Portfolio-level trends show 12/20 banks with deposit growth (avg +10% annualized) but loan declines in 7/15 (avg -1% QoQ), signaling caution amid credit deterioration (NPAs up in 9 firms). Forward guidance largely maintained/raised (e.g., PECO Core FFO +5.8%, West Pharma sales +7-9%), building Q2 catalysts; defense/industrials resilient amid geo-tensions.

12 high priority 38 medium 50 total filings
· daily

S&P 500 Energy Sector SEC Filings — April 23, 2026

Across the five filings in the USA S&P 500 Energy intelligence stream, sentiment is predominantly mixed with positive financing activity in Idaho Copper offset by revenue declines and sequential weakness in Robert Half and Baker Hughes. Key period-over-period trends reveal YoY revenue divergence: Baker Hughes +2% YoY to $6.6B despite -11% QoQ, Robert Half -4% YoY to $1.3B, Dorchester Minerals steady royalty receipts at $26.6M with oil at $51.79/bbl and gas $2.27/mcf. Capital allocation highlights shareholder returns via Dorchester's $0.475/unit Q1 2026 distribution (record date May 4, pay May 14) and Baker's divestitures targeting ~$3B proceeds in 2026, while Idaho Copper raised $1.36M in convertible notes for growth. No insider trading activity reported across filings, but strong Baker orders (+26% YoY to $8.2B, record IET RPO $33.1B) signal sector resilience amid Middle East disruptions. Portfolio-level patterns show energy services and royalties holding up better than adjacent staffing, with low oil realizations pressuring margins; actionable implications include monitoring Q2 catalysts for turnaround in sequential trends.

1 high priority 4 medium 5 total filings
· daily

Dow Jones 30 Stocks SEC Filings — April 23, 2026

The 50 filings for USA Dow Jones 30 stream (April 23, 2026) are dominated by Q1 2026 earnings from ~25 financial institutions and industrials, revealing YoY net income growth averaging ~25% across banks (e.g., OP Bancorp +30%, Bread Financial +32%) but QoQ declines in 70% of cases due to higher provisions and NIM compression (avg -5-10 bps QoQ). Revenue trends strong YoY (+10-20% in tech/industrials like ServiceNow +22%, IBM +9%, Dover +10%) but sequential softness amid supply chain/Middle East issues. Capital allocation robust with buybacks (e.g., First Citizens $900M, Mobileye $250M) and dividend hikes (e.g., ConnectOne +8.3%, Texas Capital initiated $0.20). Mixed sentiments prevail (80% mixed/neutral), with positive outliers in consumer finance (AmEx +15% NI) and credit (Bread Financial delinquency -34 bps). Forward guidance mostly reaffirmed/raised (e.g., Mobileye +2% rev, PG&E $1.64-1.66 EPS), signaling stability; M&A active (e.g., CVB Heritage close April 17, Richmond-Farmers Q2). Portfolio-level: Banks show deposit growth (avg +2-5% QoQ) offsetting loan stagnation/NPL rises (avg +20-30% QoQ), industrials divest for focus (Baker Hughes ~$3B proceeds). Implications: Tactical buys in resilient banks/tech, caution on credit risks, monitor June catalysts for blue-chips.

19 high priority 31 medium 50 total filings
· daily

S&P 500 Consumer Discretionary Sector SEC Filings — April 23, 2026

Across 50 SEC filings from April 23, 2026, primarily Q1 2026 results and proxy/M&A disclosures, financial institutions dominate with mixed performance: average loan growth ~2-5% QoQ/YoY in 10+ banks (e.g., First Citizens +0.5% loans, +5.7% deposits), but NIM compression in 6/12 reporters (avg -7bps QoQ, e.g., First Citizens -11bps) offset by strong capital returns ($900M buybacks at First Citizens, $617M at Hartford). Consumer Discretionary standouts include Tesla's +16% YoY revenue to $22.4B (automotive +20%) and Netflix's $25B buyback authorization atop $6.8B remaining, signaling conviction amid sector sales declines (Helen of Troy -6.4% FY26 YoY, massive $886M impairments). M&A activity surges with premiums (Webster +16% at $75.63/share) and closures (CVB Heritage Apr 17, Capital One Brex Apr 7), while capital allocation favors shareholders (12+ dividend hikes/buybacks, e.g., Bread +$600M authorization). Sentiment mixed (18/50), with portfolio trends showing revenue growth avg +8% YoY in reporters but margin pressure (-50bps avg in 7 firms) and rising provisions/NPAs in banks. Implications: Favor buyback-heavy names for near-term support, monitor NIM/asset quality for financials, and eye Helen turnaround via FY27 guidance ($1.75-1.82B sales). Actionable now: Accumulate Netflix/Tesla on growth/cash return strength.

16 high priority 34 medium 50 total filings
· daily

S&P 500 Healthcare Sector SEC Filings — April 23, 2026

Across 50 filings dominated by financial institutions (30+), Q1 2026 results show YoY net income growth averaging +25% in outperformers like Franklin Financial (+69%) and Univest (+25%), but QoQ declines in 6/12 banks (avg -6%), with NIM mixed: expansions +13-48bps YoY in CVB/Franklin vs compressions -5-11bps QoQ in CVB/First Citizens. Healthcare/biotech filings (8: Edgewise, Caris, Thermo Fisher, Minerva, SELLAS, Solid, Inhibrx, Lifeward) are mostly neutral proxy statements for June 3-16 annual meetings, lacking financial trends but highlighting governance enhancements. Capital allocation bullish: 10+ firms hiked dividends (avg +8%, e.g., Esquire +14%, Principal +8%), repurchases total $12B+ (Newmont $6B auth, Thermo $3B executed, Bread $690M auth), signaling conviction amid $200B+ deposit/loan growth QoQ. M&A active: GCI $310M Quintillion (healthcare wholesale support), CVB Heritage completion Apr17, Axos IRA from Capital One, Burke & Herbert LINKBANCORP May1 close. Forward guidance stable/positive (Bread low-single digit growth/7.2-7.4% loss rate; Newmont 5.3M oz gold), but mixed sentiment (18/50) from provision hikes/NPA rises. Portfolio trend: Banks ROA/ROE 1.2-1.4%/12-16%, provisions up YoY signaling credit stress; healthcare routine, no major catalysts. Implications: Buy dividend growth banks, monitor NIM/provisions for rotation; biotech proxies low alpha unless share increases pass (Solid +100% auth shares).

11 high priority 39 medium 50 total filings
· daily

S&P 500 Technology Sector SEC Filings — April 22, 2026

The 21 filings for USA S&P 500 Technology reveal strong revenue momentum in core tech names, with semiconductors and software leaders like Lam Research (+24% YoY Q3 revenue to $5.84B), ServiceNow (+22% YoY subscription revenue to $3.671B), Texas Instruments (+19% YoY Q1 revenue to $4.83B), and Intuitive Surgical (+23% YoY Q1 revenue to $2.771B) driving sector outperformance amid 9-24% YoY growth averages; IBM added 9% YoY revenue with 100bps margin expansion to 56.2%. Institutional 13F filings (Arcadia, Chemung, Madison, Muirfield) underscore conviction in mega-caps, with NVDA, AVGO, AAPL, MSFT topping portfolios (e.g., Arcadia NVDA $30.8M, Broadcom $40.9M). Capital allocation trends favor shareholders via aggressive buybacks (Intuitive $1.123B Q1, ServiceNow 20.1M shares, Mueller $75M) and dividend hikes (IBM to $1.69/share, Century 10% to $0.32). Forward guidance is mostly raised (ServiceNow FY sub rev to $15.735-15.775B +22%, IBM FY >5% CC growth), though mixed with headwinds like Middle East delays (-75bps for ServiceNow). Non-tech outliers (banks, homebuilders, health) show mixed results but lag tech growth; overall, semis/software portfolio trend signals bullish rotation with Q2 catalysts ahead.

5 high priority 16 medium 21 total filings
· daily

Nasdaq 100 Stocks SEC Filings — April 22, 2026

Across 20 filings from NASDAQ-100 constituents and related entities, key themes include robust revenue growth in semiconductors (TI +19% YoY, Lam +24% YoY, Intuitive +23% YoY) contrasting with softness in homebuilding (Century -12.6% YoY) and healthcare (CHS -6.1% YoY), while Tesla showed +16% revenue amid AI advancements. Period-over-period trends reveal 6/10 earnings reporters with YoY revenue growth averaging +18%, but mixed margins (Tesla +478bp expansion vs. others flat/compressed) and strong free cash flow generation (Tesla +117%, TI FCF +154% TTM). Capital allocation remains shareholder-friendly with buybacks (Intuitive $1.12B, Century $40M, Mueller $75M, Pineapple expansion to $15M) and dividend hikes (Century +10%, TI +4% TTM), alongside 13F snapshots confirming institutional overweight in mega-caps like NVDA, AAPL, MSFT. Positive catalysts include Robotaxi launches (Tesla), Nasdaq uplisting (First Northern), and ETF splits, but risks from inventory builds (Tesla +23% days), guidance cuts (Century FY deliveries 9.5-10.5K), and reverse splits (Creative Media). Overall, semis outperform with upward guidance, signaling portfolio rotation opportunities into tech amid broader mixed sentiment.

4 high priority 16 medium 20 total filings
· daily

S&P 500 Financials Sector SEC Filings — April 22, 2026

The 50 filings reveal a diverse snapshot dominated by ~25 neutral 13F-HR disclosures from investment managers showing heavy ETF allocations (Vanguard, Dimensional, iShares dominant in 90%+ of portfolios), with consistent overweight in tech giants (Apple/NVDA/MSFT top holdings across 20+ filers, e.g., $50M+ Apple in several) signaling broad conviction in US equities amid low active management. Q1 2026 earnings mixed: robust growth in Vertiv (+30% YoY sales, +430bps margins), Monarch Casino (+8.9% rev, +38.9% net income), but pressures in Otis (margins -130bps YoY) and Elevance Health (+1.5% rev but -34% op gain, Medicare -15.8% memberships). Financials highlights include Elevance raising FY adj EPS to >=$26.75 with $5.6B buyback auth and $1.72 div, First Northern Nasdaq uplisting Apr24, robust capital returns (Otis $400M repurchases, Monarch $17.6M shares). M&A active with National Healthcare $560M accretive acquisition (Q3 close), SPAC deals/terminations, HIVE $100M notes for capex. Forward guidance mostly raised (Vertiv FY sales +29-31% org, Otis low-mid single digits org), backlog builds (Otis mod +30%), but China weakness and costs persistent. Portfolio-level: avg rev growth ~15% YoY in reporters, margins mixed (-100bps avg compression), strong FCF enabling returns; implications favor resilient growth names amid macro caution.

10 high priority 40 medium 50 total filings